Retatrutide
2R single-vial research peptide. 5–50 mg retail; larger specifications and bulk quantities by quotation.
Representative vial format, not a batch photograph. Select your specification; final product and batch details are confirmed in writing.
- Packaging
- 1 vial
- Reference
RT5
Research Use Only · Not for Human Administration
Specifications & documents
Selected specification: 5 mg
Purity / assay, storage and handling require written confirmation for the selected lot. Applicable documents to be confirmed for the selected item.
Research reference. Retatrutide is also reported as LY3437943. The original characterization describes in-vitro assays at the glucagon (GCGR), GIP (GIPR) and GLP-1 (GLP-1R) receptors. Identity reference (PubMed) · In-vitro characterization (PubMed, 2022). Published reference data do not establish the identity, assay or quantity of the selected lot.
Request COA & HPLC for this specificationQuality & documentation review